By Rishabh Jaiswal and Sabrina Valle (Reuters) -Obesity drug developer Metsera has accepted Pfizer's $10 billion acquisition ...
DPA International on MSN
Pfizer to buy Metsera after winning bidding war with Novo Nordisk
US obesity treatment provider Metsera Inc has entered into an amended merger agreement with US pharmaceutical giant Pfizer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback